• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SynapDx

edit

SynapDx’s mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control. SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures and General Catalyst Partners. SynapDx’s corporate headquarters is located in Southborough, MA.

Recent Milestones

edit

• 
  SynapDx received () in Venture Round funding. (3/27/13)
  Posted 3/31/13 at 8:09pm via dowjones.com
• 
  SynapDx received $2M in Series C funding. (2/21/13)
  Posted 2/21/13 at 6:46pm via finsmes.com
• 
  SynapDx received $6M in Series B funding. (11/12/12)
  Posted 2/21/13 at 6:46pm via finsmes.com
• 
  SynapDx received $9M in Series A funding. (6/1/10)
  Posted 4/25/11 at 7:25pm via synapdx.com
• 
  SynapDx added Thomas Mac Mahon as Board of Directors.
  Posted 4/25/11 at 7:25pm
• 
  SynapDx added Stanley Lapidus as President, CEO and Founder.
  Posted 4/25/11 at 7:25pm
• 
  SynapDx added Hemant Taneja as Board of Directors.
  Posted 8/31/12 at 6:33am

Videos

Screenshots

edit

Sources

1. SynapDx Corporation Raises $9 Million in Series A Funding (synapdx.com) [edit]
2. SynapDxRaises $6M (finsmes.com) [edit]
3. SynapDx Secures $2M in Funding (finsmes.com) [edit]
4. SynapDx Catches Round From Football's Kraft Group for Blood Diagnostics (pevc.dowjones.com) [edit]